Joseph Emil Amegadzie

Joseph is a Postdoctoral Research Fellow specializing in Epidemiology, Health Economics, and Outcomes within the Respiratory Evaluation Sciences Program (RESP) at the University of British Columbia (UBC) in Vancouver, BC, Canada. He is also affiliated with the Centre for Heart Lung Innovation and Legacy for Airways Health, Vancouver Coastal Health Authority in BC, Canada. Before joining the RESP lab, he completed his Ph.D. in Medicine with a focus on Clinical Epidemiology and Pharmacoepidemiology from Memorial University and a major in Advanced Pharmacoepidemiology at McGill University in 2021. Joseph has leveraged real-world evidence data from the United Kingdom’s Clinical Practice Research Datalink (CPRD) to research cardio-respiratory outcomes related to asthma, COPD, and cardiovascular diseases. His postdoctoral research aims to use real-world data to generate evidence, document and understand the Economic Burden and socioeconomic determinants of Asthma and COPD. He is also a lead investigator in examining the accuracy, validating and updating cardiovascular risk-scoring tools commonly used among COPD patients. Additionally, he employs cutting-edge technologies such as Artificial Intelligence (AI) and Natural Language Processing (NLP) to streamline the updating process of clinical prediction models and implement prediction models that can predict heterogeneity of treatment effects.

EDUCATION:

• PhD Memorial University of Newfoundland
• MSc Kwame Nkrumah University of Science and Technology
• BSc (Hons.) University of Cape Coast